Partnership between Scitara and Veeva to bring optimised QC lab productivity to customers

Scitara and Veeva have announced a partnership to bring improved data infrastructures to the quality control process of drug and therapeutic market release.

Scitara will bring its scientific integration platform, SIP, and digital lab exchange DLX to complement Veeva Vault LIMS (laboratory information management system) working to streamline sample tracking, test execution, and lab processes for the optimisation of real-time batch release. The integration of Veeva Vault LIMS with Scitara’s platforms will address potential bottlenecks in the quality control of drug and therapeutic manufacturing. Customers will be provided with connected and compliant workflows, removing manual and paper-based processes and reducing the need for a second-person review. These processes will reduce the quality control timeline and accelerate the market release of a drug or therapeutic. 

Scitara CEO and founder Ajit Nagral commented: “The evolution of the lab depends on a single integrated ecosystem. The same fundamental principles apply, whether handling data from the lab or manufacturing processes. Scitara’s SIP provides a core infrastructure that establishes a dialogue across all controlling systems that guide the laboratory workflow: instruments, LIMS, e-notebooks, and manufacturing execution systems as well as the way scientists and researchers exchange data too.” 

Jason Boyd, Senior Director, Veeva Vault LIMS strategy, added: “Life sciences companies are striving to take control of data, gain a greater degree of accountability to regulatory health authorities, and streamline working practices. Bringing benchtop data from instruments and applications securely into Veeva Vault LIMS in real-time will eliminate the need for point-to-point integrations or manual data entry. This is critical for enabling data-driven decisions.” 

Source: Scitara and Veeva partner to help companies optimize QC lab productivity - Scitara Corporation